A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
One of the potential therapeutic agents for treating COVID-19 is favipiravir (FPV). This retrospective study compared the treatment of COVID-19 with (FVP group) or without (control group) favipiravir. Demographic characteristics and initial clinical indicators in the two groups were comparable. The...
Saved in:
| Main Authors: | Aigul Utegenova, Sholpan Kulzhanova, Maiya Konkayeva, Zauresh Smagulova, Nazira Beisenbieva, Gulnara Tuleshova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2022-06-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34627/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Favipiravir and Remdesivir in Combination for SARS-CoV-2 Infection in Syrian Golden Hamsters
by: Megan Neary, et al.
Published: (2024-11-01) -
Efficacy of favipiravir in COVID-19: A retrospective two center comparative study
by: Elif Tukenmez Tigen, et al.
Published: (2024-09-01) -
The Evaluation of Patients with Severe COVID-19 Pneumonia Who are Recieving Favipiravir Treatment
by: Servet ÖZTÜRK, et al.
Published: (2021-12-01) -
EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
by: L. A. Balykova, et al.
Published: (2022-03-01) -
Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro
by: Regita Aulia Rosalina, et al.
Published: (2025-03-01)